308 related articles for article (PubMed ID: 21541295)
41. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
[TBL] [Abstract][Full Text] [Related]
42. Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells.
Biscardi JS; Belsches AP; Parsons SJ
Mol Carcinog; 1998 Apr; 21(4):261-72. PubMed ID: 9585256
[TBL] [Abstract][Full Text] [Related]
43. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
Tilli TM; Carels N; Tuszynski JA; Pasdar M
Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
[TBL] [Abstract][Full Text] [Related]
44. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
45. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
46. ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells.
Nautiyal J; Yu Y; Aboukameel A; Kanwar SS; Das JK; Du J; Patel BB; Sarkar FH; Rishi AK; Mohammad RM; Majumdar AP
Mol Cancer Ther; 2010 Jun; 9(6):1503-14. PubMed ID: 20515951
[TBL] [Abstract][Full Text] [Related]
47. ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis.
Tan M; Li P; Klos KS; Lu J; Lan KH; Nagata Y; Fang D; Jing T; Yu D
Cancer Res; 2005 Mar; 65(5):1858-67. PubMed ID: 15753384
[TBL] [Abstract][Full Text] [Related]
48. Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells.
Laird AD; Li G; Moss KG; Blake RA; Broome MA; Cherrington JM; Mendel DB
Mol Cancer Ther; 2003 May; 2(5):461-9. PubMed ID: 12748308
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.
Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY
Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309
[TBL] [Abstract][Full Text] [Related]
50. ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.
Hawthorne VS; Huang WC; Neal CL; Tseng LM; Hung MC; Yu D
Mol Cancer Res; 2009 Apr; 7(4):592-600. PubMed ID: 19372587
[TBL] [Abstract][Full Text] [Related]
51. Simultaneous suppression of Src and signal transducer and activator of transcription 3 inhibits the growth of epithelial ovarian cancer cells.
Lee SW; Yoo J; Lee SH; Kim D; Kim YM; Kim YT
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):75-9. PubMed ID: 23427943
[TBL] [Abstract][Full Text] [Related]
52. Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells.
Li R; Yanjiao G; Wubin H; Yue W; Jianhua H; Huachuan Z; Rongjian S; Zhidong L
Oncotarget; 2017 Mar; 8(12):19354-19364. PubMed ID: 28423613
[TBL] [Abstract][Full Text] [Related]
53. Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.
Tekedereli I; Alpay SN; Tavares CD; Cobanoglu ZE; Kaoud TS; Sahin I; Sood AK; Lopez-Berestein G; Dalby KN; Ozpolat B
PLoS One; 2012; 7(7):e41171. PubMed ID: 22911754
[TBL] [Abstract][Full Text] [Related]
54. Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts.
Park JH; Darvin P; Lim EJ; Joung YH; Hong DY; Park EU; Park SH; Choi SK; Moon ES; Cho BW; Park KD; Lee HK; Kim MJ; Park DS; Chung IM; Yang YM
PLoS One; 2012; 7(7):e40531. PubMed ID: 22792362
[TBL] [Abstract][Full Text] [Related]
55. Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions.
Li Z; Chen G; Ding L; Wang Y; Zhu C; Wang K; Li J; Sun M; Oupicky D
Mol Ther; 2019 Dec; 27(12):2100-2110. PubMed ID: 31481310
[TBL] [Abstract][Full Text] [Related]
56. Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.
Ai M; Liang K; Lu Y; Qiu S; Fan Z
Cancer Biol Ther; 2013 Mar; 14(3):237-45. PubMed ID: 23291984
[TBL] [Abstract][Full Text] [Related]
57. TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers.
Shields BJ; Wiede F; Gurzov EN; Wee K; Hauser C; Zhu HJ; Molloy TJ; O'Toole SA; Daly RJ; Sutherland RL; Mitchell CA; McLean CA; Tiganis T
Mol Cell Biol; 2013 Feb; 33(3):557-70. PubMed ID: 23166300
[TBL] [Abstract][Full Text] [Related]
58. 15-Keto prostaglandin E
Lee EJ; Kim SJ; Hahn YI; Yoon HJ; Han B; Kim K; Lee S; Kim KP; Suh YG; Na HK; Surh YJ
Redox Biol; 2019 May; 23():101175. PubMed ID: 31129031
[TBL] [Abstract][Full Text] [Related]
59. Effects of VEGFR1
Meng D; Meng M; Luo A; Jing X; Wang G; Huang S; Luo M; Shao S; Zhao X; Liu R
J Cancer Res Clin Oncol; 2019 Feb; 145(2):411-427. PubMed ID: 30483898
[TBL] [Abstract][Full Text] [Related]
60. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
